US CDC asks states to be ready for coronavirus vaccine distribution by Nov

Three different vaccines are currently in Phase 3 trials in the U.S., during which the vaccine is given to thousands of people to test its safety and efficacy

Coronavirus, vaccine, covid
Public health officials have offered different predictions as far as when the first vaccine may be ready for distribution, with most hoping for early next year.
IANS Washington
1 min read Last Updated : Sep 03 2020 | 11:32 AM IST

The US Centers for Disease Control and Prevention (CDC) has asked states to be ready to distribute a potential coronavirus vaccine by November 1.

In a letter to state Governors and health departments on Wednesday, CDC Director Robert Redfield said the McKesson Corporation and its subsidiaries would soon be applying for permits to build distribution sites, reports Xinhua news agency.

He asked the Governors to consider waiving requirements that would delay construction or opening the sites.

"The normal time required to obtain these permits presents a significant barrier to the success of this urgent public health program," Redfield was quoted as saying in the letter.

"CDC urgently requests your assistance in expediting applications for these distribution facilities and, if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by November 1."

Several Covid-19 vaccines have already begun phase 3 clinical trials in the US.

In an interview with the Financial Times, Food and Drug Administration Commissioner Stephen Hahn said he would be willing to fast-track the coronavirus vaccine process with an emergency use authorization before phase 3 trials are over.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Testshealthcare

First Published: Sep 03 2020 | 11:22 AM IST

Next Story